Short-term S-ketamine for fibromyalgia pain relief
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This trial tests if low-dose S-ketamine, given as a short intravenous infusion, can safely improve fibromyalgia pain and other symptoms for people who haven't gotten enough relief from non-drug treatments. S-ketamine is a fast-acting medicine that blocks pain signals and may help reset how the brain processes pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and can understand English or Chinese.
- You have been diagnosed with fibromyalgia by a doctor.
- Your average pain in the last week was at least a 4 out of 10.
- You haven't tried recommended fibromyalgia medicines like pregabalin or venlafaxine before.
- You do not have certain other conditions like untreated high blood pressure, heart problems, severe sleep apnea, or history of drug abuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining two medications, pregabalin and dexmedetomidine, works better than standard treatments for fibromyalgia pain. It may help people with moderate to severe fibromyalgia who haven't found relief from non-drug therapies.
This study looks at whether ketamine given through an IV can help reduce fibromyalgia pain. It reviews past treatments and also plans new treatments to see how well they work and how safe they are.
This trial compares two strong pain medicines—fentanyl and esketamine—to see which works better for treating pain right after a traumatic injury. You would receive the medicine by spray in your nose or through a vein before going to the hospital.
This trial tests a combination of two medicines (pregabalin and venlafaxine) for people with fibromyalgia whose pain is moderate to severe and has not been helped enough by non-drug treatments. The goal is to see if the combination works better and is safe.
This study looks at whether giving esketamine through a vein can help reduce long-term pain in people with complex regional pain syndrome (CRPS). You may be able to join if your CRPS diagnosis matches specific international criteria and you can safely take the study medicine.
This trial is testing whether a combination of ketamine and talk therapy can help people with depression that hasn't responded to other treatments. You will receive ketamine in a safe, supervised setting while working with a therapist.
Hear when a new Fibromyalgia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.